Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer

Authors:

Abstract
No abstract available
Funding Information
  • Fondation ARC pour la Recherche sur le Cancer (20191209484)

This publication has 28 references indexed in Scilit: